Related Experiment Video
Updated: May 25, 2026
06:34
Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Drug development: longer-lived proteins
Stephan Kontos1, Jeffrey A Hubbell
1Institute of Bioengineering, Ecole Polytechnique Fédérale Lausanne, Lausanne, Switzerland.
Chemical Society Reviews
|February 8, 2012
Summary
Protein therapeutics can be cleared quickly by the body, reducing their effectiveness. This review covers methods like chemical modification and protein engineering to extend the circulation time of these vital drugs.
Area of Science:
- Biochemistry
- Biophysics
- Pharmacology
Background:
- Protein therapeutics are effective drugs for treating diseases.
- The body's clearance mechanisms can reduce the efficacy and circulation time of protein therapeutics.
- Understanding these mechanisms is crucial for drug development.
Purpose of the Study:
- To introduce the concepts of physiological protein clearance.
- To describe chemical modification and protein engineering strategies.
- To enhance the lifespan of protein therapeutics.
Main Methods:
- Review of physiological protein clearance pathways.
- Analysis of chemical modification techniques.
- Exploration of protein engineering approaches.
Main Results:
- Physiological clearance significantly impacts protein therapeutic pharmacokinetics.
- Chemical modifications can alter protein properties to reduce clearance.
- Protein engineering offers tailored solutions for improved stability and extended circulation.
Conclusions:
- Extending protein therapeutic lifespan is achievable through strategic modifications.
- Chemical and engineering approaches are key to overcoming clearance limitations.
- Optimizing protein therapeutics enhances their clinical utility and patient outcomes.
Related Concept Videos
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:30Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
01:26Bacterial Protein Maturation
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
01:09Recombinant DNA
Overview